Title : Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma.

Pub. Date : 2021 Jul 28

PMID : 34366628






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Y-box binding protein 1 augments sorafenib resistance via the PI3K/Akt signaling pathway in hepatocellular carcinoma. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
2 Furthermore, KEGG pathway enrichment analysis of DGE-seq demonstrated that the phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt) signaling pathway was essential for the sorafenib resistance induced by YB-1. Sorafenib AKT serine/threonine kinase 1 Homo sapiens
3 Finally, YB-1 suppressed the inactivation of the PI3K/Akt signaling pathway induced by sorafenib, and the blockade of the PI3K/Akt signaling pathway by LY294002 mitigated YB-1-induced sorafenib resistance. Sorafenib AKT serine/threonine kinase 1 Homo sapiens